Supernus Pharmaceuticals, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology

Other Names/Subsidiaries

  • Adamas Pharmaceuticals, Inc.
  • Biscayne Neurotherapeutics, Inc.
  • Biscayne Neurotherapeutics Australia Pty, Ltd
  • Shire plc
  • Shire Laboratories Inc
See more in Biomedtracker

Latest on Supernus Pharmaceuticals, Inc.

Pink Sheet

As US FDA Communications Freeze Thaws, Approvals Accumulate

 
• By Bridget Silverman

The US Food and Drug Administration is starting to post information to key drug databases on its website again after most of its public communications were halted 21 January. The Center for Drug Evalu

Scrip

AbbVie Gets Second Parkinson’s Drug With Vyalev Approval

 
• By Joseph Haas

After a quick resolution of a manufacturing-related complete response letter, AbbVie Inc. has the next piece in place for its Parkinson’s disease franchise. The US Food and Drug Administration cleared

Pink Sheet

Rare Diseases Rule, But Some Common Conditions Stand Out In Pending US Applications

 
• By Bridget Silverman

Rare diseases are almost certain to remain one of the biggest areas for novel drug development in 2024, but the orphan drug pipeline will be making space for some novel therapies for common conditions

Scrip

Bukwang Adds To Stacking Mid-Stage Failures In Parkinson's

 
• By Jung Won Shin and Kosh Naran

More mid-stage clinical trial failures are piling up in the Parkinson’s disease space, with the latest disappointment coming from South Korea's Bukwang Pharmaceutical Co., Ltd. , underlining the diff